PROGNOSING METHOD OF RISK OF HIV INTRAUTERIN FOETUS INFECTION FROM HIV INFECTED MOTHER DURING THE FIRST SIX MONTHS OF PREGNANCY
Invention relates to medicine, particularly to infectious diseases and molecular genetic investigations. It may be used in prognosing risk of intrauterin HIV infection in foetuses during the first six months of pregnancy.The method provides for detection of TNF?, IL2, IL4, IL12?, IL10, INF? mutation...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; lav |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | VĪKSNA Ludmila JANUŠKEVIČA Inga KASJKO Diāna STOROŽENKO Jeļena STŪRE Gunta HAGINA Elvīra EGLĪTE Jeļena ROZENTĀLE Baiba JASINSKIS Vladislavs |
| description | Invention relates to medicine, particularly to infectious diseases and molecular genetic investigations. It may be used in prognosing risk of intrauterin HIV infection in foetuses during the first six months of pregnancy.The method provides for detection of TNF?, IL2, IL4, IL12?, IL10, INF? mutations in mother blood leukocytes and measuring level of IL2, IL12 cytokines in peripherial blood serum of pregnant HIV infected mother.
Izgudrojums attiecas uz medicīnu, konkrēti uz infekcijas slimībām un molekulāri-ģenētiskiem pētījumiem, īpaši uz augļa HIV inficēšanās riska prognozēšanu grūtniecības pirmajos sešos mēnešos. Tiek piedāvāta metode, kurā mātes asins leikocītos tiek noteiktas TNFɑ, IL2, IL4, IL12β, IL10, INFɣ mutācijas, bet mātes asins serumā nosaka interleikīnu IL2, IL12 daudzumu. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_LV15133A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>LV15133A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_LV15133A3</originalsourceid><addsrcrecordid>eNqFjDEKwkAQRdNYiHoEYS5gEYIHCMlsdtDshNmJaBWCrJVoIPZe3V1Ib_U_733-Ovt2wo1jT66BFtVyDWxAyJ9SWroAOZWyVxRyYBi19xEZrJQ4AuF2WSWENbSsFgXqXtJl7GBIvIKna3ROrU_HnWDjSlfdttnqMT7nsFtyk-0NamUPYXoPYZ7Ge3iFz3C-5Me8KMrin_8BfzA6fA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PROGNOSING METHOD OF RISK OF HIV INTRAUTERIN FOETUS INFECTION FROM HIV INFECTED MOTHER DURING THE FIRST SIX MONTHS OF PREGNANCY</title><source>esp@cenet</source><creator>VĪKSNA Ludmila ; JANUŠKEVIČA Inga ; KASJKO Diāna ; STOROŽENKO Jeļena ; STŪRE Gunta ; HAGINA Elvīra ; EGLĪTE Jeļena ; ROZENTĀLE Baiba ; JASINSKIS Vladislavs</creator><creatorcontrib>VĪKSNA Ludmila ; JANUŠKEVIČA Inga ; KASJKO Diāna ; STOROŽENKO Jeļena ; STŪRE Gunta ; HAGINA Elvīra ; EGLĪTE Jeļena ; ROZENTĀLE Baiba ; JASINSKIS Vladislavs</creatorcontrib><description>Invention relates to medicine, particularly to infectious diseases and molecular genetic investigations. It may be used in prognosing risk of intrauterin HIV infection in foetuses during the first six months of pregnancy.The method provides for detection of TNF?, IL2, IL4, IL12?, IL10, INF? mutations in mother blood leukocytes and measuring level of IL2, IL12 cytokines in peripherial blood serum of pregnant HIV infected mother.
Izgudrojums attiecas uz medicīnu, konkrēti uz infekcijas slimībām un molekulāri-ģenētiskiem pētījumiem, īpaši uz augļa HIV inficēšanās riska prognozēšanu grūtniecības pirmajos sešos mēnešos. Tiek piedāvāta metode, kurā mātes asins leikocītos tiek noteiktas TNFɑ, IL2, IL4, IL12β, IL10, INFɣ mutācijas, bet mātes asins serumā nosaka interleikīnu IL2, IL12 daudzumu.</description><language>eng ; lav</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS OR TEST PAPERS THEREFOR ; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ; ENZYMOLOGY ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS ; METALLURGY ; MICROBIOLOGY ; MUTATION OR GENETIC ENGINEERING ; PHYSICS ; PROCESSES OF PREPARING SUCH COMPOSITIONS ; SPIRITS ; TESTING ; VINEGAR ; WINE</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160620&DB=EPODOC&CC=LV&NR=15133A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160620&DB=EPODOC&CC=LV&NR=15133A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>VĪKSNA Ludmila</creatorcontrib><creatorcontrib>JANUŠKEVIČA Inga</creatorcontrib><creatorcontrib>KASJKO Diāna</creatorcontrib><creatorcontrib>STOROŽENKO Jeļena</creatorcontrib><creatorcontrib>STŪRE Gunta</creatorcontrib><creatorcontrib>HAGINA Elvīra</creatorcontrib><creatorcontrib>EGLĪTE Jeļena</creatorcontrib><creatorcontrib>ROZENTĀLE Baiba</creatorcontrib><creatorcontrib>JASINSKIS Vladislavs</creatorcontrib><title>PROGNOSING METHOD OF RISK OF HIV INTRAUTERIN FOETUS INFECTION FROM HIV INFECTED MOTHER DURING THE FIRST SIX MONTHS OF PREGNANCY</title><description>Invention relates to medicine, particularly to infectious diseases and molecular genetic investigations. It may be used in prognosing risk of intrauterin HIV infection in foetuses during the first six months of pregnancy.The method provides for detection of TNF?, IL2, IL4, IL12?, IL10, INF? mutations in mother blood leukocytes and measuring level of IL2, IL12 cytokines in peripherial blood serum of pregnant HIV infected mother.
Izgudrojums attiecas uz medicīnu, konkrēti uz infekcijas slimībām un molekulāri-ģenētiskiem pētījumiem, īpaši uz augļa HIV inficēšanās riska prognozēšanu grūtniecības pirmajos sešos mēnešos. Tiek piedāvāta metode, kurā mātes asins leikocītos tiek noteiktas TNFɑ, IL2, IL4, IL12β, IL10, INFɣ mutācijas, bet mātes asins serumā nosaka interleikīnu IL2, IL12 daudzumu.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS OR TEST PAPERS THEREFOR</subject><subject>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</subject><subject>ENZYMOLOGY</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PHYSICS</subject><subject>PROCESSES OF PREPARING SUCH COMPOSITIONS</subject><subject>SPIRITS</subject><subject>TESTING</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFjDEKwkAQRdNYiHoEYS5gEYIHCMlsdtDshNmJaBWCrJVoIPZe3V1Ib_U_733-Ovt2wo1jT66BFtVyDWxAyJ9SWroAOZWyVxRyYBi19xEZrJQ4AuF2WSWENbSsFgXqXtJl7GBIvIKna3ROrU_HnWDjSlfdttnqMT7nsFtyk-0NamUPYXoPYZ7Ge3iFz3C-5Me8KMrin_8BfzA6fA</recordid><startdate>20160620</startdate><enddate>20160620</enddate><creator>VĪKSNA Ludmila</creator><creator>JANUŠKEVIČA Inga</creator><creator>KASJKO Diāna</creator><creator>STOROŽENKO Jeļena</creator><creator>STŪRE Gunta</creator><creator>HAGINA Elvīra</creator><creator>EGLĪTE Jeļena</creator><creator>ROZENTĀLE Baiba</creator><creator>JASINSKIS Vladislavs</creator><scope>EVB</scope></search><sort><creationdate>20160620</creationdate><title>PROGNOSING METHOD OF RISK OF HIV INTRAUTERIN FOETUS INFECTION FROM HIV INFECTED MOTHER DURING THE FIRST SIX MONTHS OF PREGNANCY</title><author>VĪKSNA Ludmila ; JANUŠKEVIČA Inga ; KASJKO Diāna ; STOROŽENKO Jeļena ; STŪRE Gunta ; HAGINA Elvīra ; EGLĪTE Jeļena ; ROZENTĀLE Baiba ; JASINSKIS Vladislavs</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_LV15133A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; lav</language><creationdate>2016</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS OR TEST PAPERS THEREFOR</topic><topic>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</topic><topic>ENZYMOLOGY</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PHYSICS</topic><topic>PROCESSES OF PREPARING SUCH COMPOSITIONS</topic><topic>SPIRITS</topic><topic>TESTING</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>VĪKSNA Ludmila</creatorcontrib><creatorcontrib>JANUŠKEVIČA Inga</creatorcontrib><creatorcontrib>KASJKO Diāna</creatorcontrib><creatorcontrib>STOROŽENKO Jeļena</creatorcontrib><creatorcontrib>STŪRE Gunta</creatorcontrib><creatorcontrib>HAGINA Elvīra</creatorcontrib><creatorcontrib>EGLĪTE Jeļena</creatorcontrib><creatorcontrib>ROZENTĀLE Baiba</creatorcontrib><creatorcontrib>JASINSKIS Vladislavs</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>VĪKSNA Ludmila</au><au>JANUŠKEVIČA Inga</au><au>KASJKO Diāna</au><au>STOROŽENKO Jeļena</au><au>STŪRE Gunta</au><au>HAGINA Elvīra</au><au>EGLĪTE Jeļena</au><au>ROZENTĀLE Baiba</au><au>JASINSKIS Vladislavs</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PROGNOSING METHOD OF RISK OF HIV INTRAUTERIN FOETUS INFECTION FROM HIV INFECTED MOTHER DURING THE FIRST SIX MONTHS OF PREGNANCY</title><date>2016-06-20</date><risdate>2016</risdate><abstract>Invention relates to medicine, particularly to infectious diseases and molecular genetic investigations. It may be used in prognosing risk of intrauterin HIV infection in foetuses during the first six months of pregnancy.The method provides for detection of TNF?, IL2, IL4, IL12?, IL10, INF? mutations in mother blood leukocytes and measuring level of IL2, IL12 cytokines in peripherial blood serum of pregnant HIV infected mother.
Izgudrojums attiecas uz medicīnu, konkrēti uz infekcijas slimībām un molekulāri-ģenētiskiem pētījumiem, īpaši uz augļa HIV inficēšanās riska prognozēšanu grūtniecības pirmajos sešos mēnešos. Tiek piedāvāta metode, kurā mātes asins leikocītos tiek noteiktas TNFɑ, IL2, IL4, IL12β, IL10, INFɣ mutācijas, bet mātes asins serumā nosaka interleikīnu IL2, IL12 daudzumu.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; lav |
| recordid | cdi_epo_espacenet_LV15133A |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PHYSICS PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS TESTING VINEGAR WINE |
| title | PROGNOSING METHOD OF RISK OF HIV INTRAUTERIN FOETUS INFECTION FROM HIV INFECTED MOTHER DURING THE FIRST SIX MONTHS OF PREGNANCY |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T13%3A45%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=V%C4%AAKSNA%20Ludmila&rft.date=2016-06-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ELV15133A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |